Cargando...
Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer
PURPOSE OF REVIEW: Compensatory mechanisms leading to increased androgen receptor expression and activity after androgen ablation or anti-androgen treatment have been identified in prostate cancer. After hydroxyflutamide and bicalutamide were used in therapy of prostate cancer over many years, novel...
Guardado en:
| Publicado en: | Curr Mol Biol Rep |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer International Publishing
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5700216/ https://ncbi.nlm.nih.gov/pubmed/29214142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40610-017-0079-1 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|